These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2192716)

  • 21. The effects of roxatidine acetate on 24-hour intragastric acidity. Investigations in healthy volunteers and comparison with ranitidine and placebo.
    Merki HS; Witzel L; Kaufmann D; Kempf M; Neumann J; Scheurle E; Röhmel J; Walt RP
    Drugs; 1988; 35 Suppl 3():69-75. PubMed ID: 2905252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enteric-coated charcoal as a means of blinding studies comparing bismuth and H2-receptor antagonists.
    Yates S; Barnett C; Peterson WL
    Am J Gastroenterol; 1992 Aug; 87(8):981-4. PubMed ID: 1642222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of single and multiple doses of oral ranitidine on the gastric transit of an indigestible capsule in humans.
    Mojaverian P; Vlasses PH; Parker S; Warner C
    Clin Pharmacol Ther; 1990 Mar; 47(3):382-8. PubMed ID: 2178854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The effect of ranitidine on gastric pH measured by continuous monitoring over 24 hours in healthy subjects. Comparison of 2 methods of administration: 150 mg morning and night, vs 300 mg in a single dose at night].
    Bonfils S; Guedon C; Vallot T; Congard P; Garcia del Risco F; Galmiche JP; Denis P; Pappo M
    Ann Gastroenterol Hepatol (Paris); 1988 Oct; 24(5):221-5. PubMed ID: 3207350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the H2 receptor antagonist and gastric acid antisecretory properties of Wy-45,727.
    Nielsen ST
    J Pharmacol Exp Ther; 1987 Aug; 242(2):607-13. PubMed ID: 2886646
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Twenty-four-hour intragastric pH: tolerance within 5 days of continuous ranitidine administration.
    Lachman L; Howden CW
    Am J Gastroenterol; 2000 Jan; 95(1):57-61. PubMed ID: 10638559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of raising gastric pH with ranitidine on the absorption and elimination of theophylline from a sustained-release theophylline tablet.
    Betlach CJ; Straughn AB; Meyer MC; Bialer M; Vashi VI; Liebermann P; González MA
    Pharm Res; 1991 Dec; 8(12):1516-9. PubMed ID: 1808616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nocturnal acid suppression with a new H2 receptor antagonist--nizatidine.
    Dammann HG; Gottlieb WR; Walter TA; Dreyer M; Müller P; Simon B; Keohane P
    Hepatogastroenterology; 1986 Oct; 33(5):217-20. PubMed ID: 2879782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of long-term acid gastric inhibition on bacterial translocation in cirrhotic rats.
    Sánchez E; Soriano G; Mirelis B; Gonzalez B; Nieto JC; Vidal S; Guarner-Argente C; Juárez C; Monés J; Guarner C
    Eur J Gastroenterol Hepatol; 2015 May; 27(5):570-6. PubMed ID: 25822866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The cephalic and gastric phases of gastric secretion during H2-antagonist treatment.
    Merki HS; Wilder-Smith CH; Walt RP; Halter F
    Gastroenterology; 1991 Sep; 101(3):599-606. PubMed ID: 1860625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Onset of action of antisecretory drugs: beneficial effects of a rapid increase in intragastric pH in acid reflux disease.
    Pipkin GA; Mills JG
    Scand J Gastroenterol Suppl; 1999; 230():3-8. PubMed ID: 10499455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinetics of the inhibition of food-stimulated secretion by ranitidine in dogs.
    Frislid K; Guldvog I; Berstad A
    Eur Surg Res; 1985; 17(6):360-5. PubMed ID: 2415364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of nasogastric suction and ranitidine on the calculated gastric intramucosal pH.
    Kolkman JJ; Groeneveld AB
    Intensive Care Med; 1997 Jan; 23(1):132. PubMed ID: 9037660
    [No Abstract]   [Full Text] [Related]  

  • 34. Influence of acid secretory status on absorption of omeprazole from enteric coated granules.
    Andersson T; Bergstrand R; Cederberg C
    Br J Clin Pharmacol; 1991 Mar; 31(3):275-8. PubMed ID: 2054268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antisecretory and antiulcer activities of a potent new histamine H2-receptor antagonist with an intermediate duration of action.
    Borella L; Russell J; Rimele TJ; Grimes D; Failli A; Mir GN
    Arzneimittelforschung; 1988 Mar; 38(3):366-72. PubMed ID: 2898247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. pH-feedback controlled infusions of ranitidine are no more effective than fixed-dose infusions in reducing gastric acidity and variability in antisecretory responses.
    Wilder-Smith CH; Halter F; Häcki W; Merki HS
    Br J Clin Pharmacol; 1992 May; 33(5):487-93. PubMed ID: 1524960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo and in vitro effects of CM 57755, a new gastric antisecretory agent acting on histamine H2 receptors.
    Lavezzo A; Manzoni L; Aureggi G; Nisato D; Bianchetti A; Carminati P
    Int J Tissue React; 1984; 6(2):155-65. PubMed ID: 6145676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction of postprandial gastric acidity and pepsin concentration by ranitidine and antacids in healthy volunteers.
    Berstad A; Rydning A; Kolstad B; Frislid K
    Scand J Gastroenterol Suppl; 1981 Jun; 69():67-73. PubMed ID: 6119785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effect of pretreatment with ranitidine on the pharmacokinetics and gastrointestinal transit of a sustained-release theophylline preparation].
    Wilson CG; Washington N; Greaves JL; Blackshaw PE; Perkins AC; Barkworth MF; Rehm KD
    Arzneimittelforschung; 1998 May; 48(5A):561-8. PubMed ID: 9676345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histamine H2-receptor antagonist action of ebrotidine. Effects on gastric acid secretion, gastrin levels and NSAID-induced gastrotoxicity in the rat.
    Palop D; Agut J; Márquez M; Conejo L; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1997 Apr; 47(4A):439-46. PubMed ID: 9205740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.